|
Report No. : |
316754 |
|
Report Date : |
11.04.2015 |
IDENTIFICATION DETAILS
|
Name : |
MISSIONPNARMA
AS |
|
|
|
|
Registered Office : |
Vassingeradvej 9, Lynge, |
|
|
|
|
Country : |
Denmark |
|
|
|
|
Financials (as on) : |
2013 |
|
|
|
|
Date of Incorporation : |
06.12.2002 |
|
|
|
|
Com. Reg. No.: |
26902398 |
|
|
|
|
Legal Form : |
Limited company |
|
|
|
|
Line of Business : |
Wholesale
of Pharmaceutical and Nursing Goods. |
|
|
|
|
No. of Employees : |
45 [2013] |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – December 31, 2014
|
Country Name |
Previous Rating (30.09.2014) |
Current Rating (31.12.2014) |
|
Denmark |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
DENMARK - ECONOMIC OVERVIEW
This thoroughly modern market
economy features a high-tech agricultural sector, state-of-the-art industry with
world-leading firms in pharmaceuticals, maritime shipping and renewable energy,
and a high dependence on foreign trade. Denmark is a member of the European
Union (EU); Danish legislation and regulations conform to EU standards on
almost all issues. Danes enjoy a high standard of living and the Danish economy
is characterized by extensive government welfare measures and an equitable
distribution of income. Denmark is a net exporter of food and energy and enjoys
a comfortable balance of payments surplus, but depends on imports of raw
materials for the manufacturing sector. Within the EU, Denmark is among the
strongest supporters of trade liberalization. After a long consumption-driven
upswing, Denmark's economy began slowing in 2007 with the end of a housing
boom. Housing prices dropped markedly in 2008-09 and, following a short respite
in 2010, have since continued to decline. Household indebtedness is still
relatively high at more than 275% of gross disposable income in the first half
of 2013. The global financial crisis has exacerbated this cyclical slowdown
through increased borrowing costs and lower export demand, consumer confidence,
and investment. Denmark made a modest recovery in 2010, in part because of
increased government spending; however, the country experienced a technical
recession in late 2010-early 2011. Historically low levels of unemployment rose
sharply with the recession and have remained at about 6% in 2010-13, based on
the national measure, about two-thirds average EU unemployment. An impending
decline in the ratio of workers to retirees will be a major long-term issue.
Denmark maintained a healthy budget surplus for many years up to 2008, but the
budget balance swung into deficit in 2009, where it remains. In spite of the
deficits, the new coalition government delivered a modest stimulus to the
economy in 2012. Nonetheless, Denmark's fiscal position remains among the
strongest in the EU with public debt at about 46% of GDP in 2013. Despite
previously meeting the criteria to join the European Economic and Monetary
Union (EMU), so far Denmark has decided not to join, although the Danish krone
remains pegged to the euro.
|
Source
: CIA |
|
business Name |
Missionpnarma A/S |
|
Country |
DENMARK |
|
Company
Registration Number |
26902398 |
|
Activity
Code |
464610 |
|
Activity
Description |
Wholesale of pharmaceutical and nursing goods |
|
Company
Status |
Active (Active) |
|
Latest
Turnover Figure |
537.927.000 DKK |
|
Latest
Shareholder Equity Figure |
124.385.000 DKK |
|
Local
Description |
Businesses
at this level are regarded as having excellent creditworthiness. Small
businesses only have a limited possibility of achieving this level. Businesses
at this level are in a class by themselves and will have results or financial
foundations which are among the best in the country. The credit risk is
regarded as minimal. |
|
business
Name |
Missionpharma A/S |
|
Registered
Company Name |
Missionpharma A/S |
|
Company
Registration Number |
26902398 |
|
Country |
DENMARK |
|
Date
of Company Registration |
06/12/2002 |
|
Legal
Form |
Limited company |
|
Company
Status |
Active (Active) |
|
Currency
of this Report |
DKK |
|
Principal
Activity Code |
464610 |
|
Principal
Activity Description |
Wholesale of pharmaceutical and nursing goods |
|
Contact
Address |
Vassingeradvej 9, Lynge 3540 |
|
Contact
Telephone Number |
48163200 |
|
Address |
Country |
Telephone |
|
Vassingeradvej 9, Lynge 3540 |
DENMARK |
48163200 |
|
Activity
Code |
Activity Description |
|
464610 |
Wholesale of
pharmaceutical and nursing goods |
|
464620 |
Wholesale of medical and
hospital goods |
|
Year |
Number of Employees |
|
2013 |
45 |
|
2012 |
51 |
|
2012 |
50 |
|
Real Estate |
No |
|
Type |
Name |
|
Business name |
International Project
Services A/S |
|
Business name |
Missionpharma
International A/S |
|
Business name |
Missionpharma
International Project Services A/S |
|
Business name |
Missionpharma
International Relief Services A/S |
Export - Europe
Import - -
|
Type |
Text |
|
No. of employees |
According to information from the business the number of
employees is 50. |
|
Historical data |
In 2003 the company took over the activities previously
carried on by Missionpharma Interna. Proj. Services A/S (16929484.) |
|
Capital conditions |
fully paid up |
Date Format MM-DD
Accounts Start Date 01-01
Accounts End Date 12-31
|
Profit
and Loss |
|
|
|
|
Financial Year |
2013 |
2012 |
2012 |
|
Number of Weeks |
52 |
35 |
52 |
|
Currency |
DKK |
DKK |
DKK |
|
Revenue |
537.927.000 |
387.645.000 |
619.055.000 |
|
Operating Profit |
69.046.000 |
48.453.000 |
36.595.000 |
|
Retained Profit |
44.083.000 |
35.246.000 |
26.429.000 |
|
Balance Sheet |
|
|
|
|
Financial Year |
2013 |
2012 |
2012 |
|
Number of Weeks |
52 |
35 |
52 |
|
Currency |
DKK |
DKK |
DKK |
|
TOTAL ASSETS |
214.241.000 |
230.154.000 |
246.801.000 |
|
Other Reserves |
124.385.000 |
106.596.000 |
85.828.000 |
|
Nominal Share Capital |
1.000.000 DKK |
|
Shareholder |
Address |
% Shares Held |
|
P. Ginnerup ApS |
Vassingerødvej 9 Lynge 3540 DNK |
60 |
|
Name |
Appointment Date |
Position |
|
Kim Erik Ginnerup |
03/04/2013 |
Managing director |
|
Poul Lindof |
05/01/2010 |
General manager |
|
Jean-Marc Pierre René Leccia |
20/07/2012 |
Chairman |
|
Denis Georges Fernand Maurice |
20/07/2012 |
Deputy Chairman |
|
Eric Pierre Jean Muris |
20/07/2012 |
Member of the board |
|
Name |
Appointment Date |
Position |
|
Kim Erik Ginnerup |
03/01/2011 |
Member of the board |
|
Poul Lindof |
29/01/2015 |
Finance |
|
Ultimate Holding Company Name |
P. Ginnerup ApS |
|
Ultimate Holding Company Country |
|
|
Subsidiary Name |
Country |
|
PharmaDanica A/S |
DENMARK |
|
Missionpharma Logistics Pvt Ltd |
INDIA |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.62.37 |
|
|
1 |
Rs.91.60 |
|
Euro |
1 |
Rs.66.49 |
INFORMATION DETAILS
|
Analysis Done by
: |
SUB |
|
|
|
|
Report Prepared
by : |
NIT |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
|
-- |
NB |
New Business |
-- |
|
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major sections
of this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.